In the latest setback in the Department Justice Antitrust Division’s (DOJ) attempts to prosecute “no-poach” agreements criminally, a federal judge acquitted from the bench all six defendant employees of aerospace engineering...more
In October, the Department of Justice Antitrust Division announced its first criminal attempted monopolization charges in more than 40 years. In the case, U.S. v. Zito, Nathan Nephi Zito, the owner of a Montana paving...more
12/1/2022
/ Anti-Competitive ,
Antitrust Division ,
Corruption ,
Criminal Investigations ,
Criminal Prosecution ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Guilty Pleas ,
Monopolization ,
Section 2 ,
Sherman Act
On February 25, 2019, in FTC v. Shire ViroPharma, Inc., the U.S. Court of Appeals for the Third Circuit confirmed that the Federal Trade Commission (FTC) cannot plead its way into federal court via Section 13(b) of the FTC...more
3/2/2019
/ Administrative Proceedings ,
Administrative Remedies ,
Anti-Competitive ,
Antitrust Violations ,
Appeals ,
Disgorgement ,
Dismissals ,
Federal Pleading Requirements ,
Federal Trade Commission (FTC) ,
FTC Act ,
Generic Drugs ,
Illegal Profits ,
Injunctive Relief ,
Motion to Dismiss ,
Pharmaceutical Industry ,
Remedies ,
Restitution ,
Unfair Competition
The U.S. Supreme Court’s 2013 decision in Federal Trade Commission v. Actavis, Inc. triggered a flurry of judicial activity in relation to pharmaceutical patent settlements allegedly involving reverse payments from patent...more